Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rob Isbitts

Invest Like Warren Buffett and Buy Wide-Moat Stocks Via This ETF Ahead of a Major Market Shift

With index concentration at an all-time high, the stage is perfectly set for this ETF to make a solid comeback.

How Overzealous Option Traders Are Making 3X Leveraged ETFs Look Like Saviors

How Overzealous Option Traders Are Making 3X Leveraged ETFs Look Like Saviors

Warning: A key part of the options market you may be relying on is no longer working.

The SpaceX IPO Is a Bet That Retail Investors Love Elon Musk So Much They’ll Fund His Money-Losing Empire

The SpaceX IPO Is a Bet That Retail Investors Love Elon Musk So Much They’ll Fund His Money-Losing Empire

The SpaceX IPO is an optical illusion hiding in plain sight.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Wall Street Wants You to Chase the SpaceX, Anthropic, and OpenAI IPO Hype. History Tells Us That’s a Dangerous Game.

Rushing to own the latest “hot” stock can make you a financial victim in just a matter of days… or even hours.

A ‘Golden Dome’ Has Formed on the Chart of This Gold Mining ETF. The Bull Rally in Precious Metals Has Run Out of Steam.

The best days of the gold trade are firmly in the rearview mirror.

The S&P 500’s Price Is Getting Better Every Week, But This Indicator Keeps Getting Worse. Why 52% Could Be The Market’s Tragic Number.

Right now, the top 25 largest stocks in the S&P 500 account for a staggering 52% of the total index weight.

Nvidia and Micron Stocks Are Almost Exclusively Driving S&P Earnings Strength. These 3 Very Real Risks Could End It All.

Goldman Sachs data shows that together, Micron and Nvidia are responsible for one-third of all S&P 500 earnings growth in 2026.

inkl

Read news from The Economist, FT, and more,
with one subscription

The Ghosts of 1987 Appear: Kevin Warsh, Alan Greenspan, and How to Invest Safely Under a New Fed Chair

The Ghosts of 1987 Appear: Kevin Warsh, Alan Greenspan, and How to Invest Safely Under a New Fed Chair

When a new Fed chair takes office at the White House amidst rising inflation, a bleeding bond market, and a speculative stock mania, the ghosts of 1987 aren’t just a curiosity. They are spirits to fear.

Don’t Ignore Basic Bond Math and Jump Into TIPS: The ‘Inflation Hedge’ Story Isn’t Everything

Don’t Ignore Basic Bond Math and Jump Into TIPS: The ‘Inflation Hedge’ Story Isn’t Everything

With sticky inflation re-emerging as the dominant macro story, retail investors are aggressively searching for a shield to protect their purchasing power.

Telecom Stocks Are Surging Ahead of the SpaceX IPO. This Chart Reminds Us All Rockets Come Crashing Back to Earth Eventually.

Telecom Stocks Are Surging Ahead of the SpaceX IPO. This Chart Reminds Us All Rockets Come Crashing Back to Earth Eventually.

SpaceX is creating a halo around even old-school telecom stocks. The glow will soon fade.

This Sports-Betting ETF Is Set to Stage a Comeback in the Second Half of 2026

This Sports-Betting ETF Is Set to Stage a Comeback in the Second Half of 2026

The thrill is gone when it comes to investor interest in the Roundhill Sports Betting & iGaming ETF (BETZ) . This exchange-traded fund (ETF) debuted with some fanfare back in June 2020. You’ll recall that it was near the apex of the pandemic, when workers all around the planet were...

When Growth Stocks Finally Collapse, You’ll Want This 1 Anti-Beta ETF in Your Portfolio

When Growth Stocks Finally Collapse, You’ll Want This 1 Anti-Beta ETF in Your Portfolio

Knowing how to use this tool will help ensure you are a step ahead of the game the next time the stock market rolls over.

Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Go beyond the broad index and find which segment of healthcare best suits your portfolio needs now.

Rising Rates Are Threatening to Kill the Zombies and Send Small-Cap Stocks Plunging

Rising Rates Are Threatening to Kill the Zombies and Send Small-Cap Stocks Plunging

A consequential threat to the market is quietly developing in fixed income.

Get all your
news in one place.

100's of premium titles.
One news app.

Why the Earnings Report Reaction in Nvidia Stock Matters So Much More This Time

The entire financial complex is currently hanging by a thread. Or rather, a microchip.

Consumer Staples Are Losing Their Safe-Haven Status. Here's Why.

There’s a large camp among Wall Street analysts that assumes when the technology and other growth sectors plunge, the safety trade is in consumer staples. Here's why that might be changing.

The $43 Billion ETF Hiding in Plain Sight. Why DIA Might Outperform SPY and QQQ for the Rest of 2026.

If the market maintains its all-time highs, DIA is poised to catch up as investors seek out the relatively cheaper pockets of the large-cap universe.

The VIX and SPY Are Falling at the Same Time. Don’t Get Trapped by Volatility Hiding in a Market Blind Spot.

Just because the VIX is falling does not mean there is no volatility. It is just hiding where traders are not looking now.

Get all your
news in one place.

100's of premium titles.
One news app.

These 3 AI ETFs Could Be the First to Kill the Stock Market Rally

The alarm bells are not ringing yet, but keep your ears open.

Colgate-Palmolive May Be Boring, But CL Stock Has Great Upside Potential Here

Colgate-Palmolive (CL) shares are making the most of the latest market attempt to broaden. The stock currently maintains a 56% “BUY” technical opinion from Barchart, as short-term momentum indicators begin to turn constructive following a solid move up from April’s $82 bottom. CL is trading below its 52-week high of...

The Cerebras IPO Is a Clear Sign That the Stock Market Is ‘Wafer Thin’

As a career investor, I am not buying into the Cerebras IPO hype.

1 Rapidly Deteriorating ETF Screams That ‘Shop ‘Til You Drop’ Americans Have All But Keeled Over

The SPDR S&P Retail ETF (XRT) has long been the primary barometer for the health of the American consumer, and lately, the readings are turning decidedly cold.

Yield Is No Longer King: What These 5 Dividend ETFs Are Telling Investors

Dividend investing has changed, and yield is misunderstood or misused by many investors. Let's take a closer look at 5 ETFS and discuss what dividend investors should know.

The DRAM ETF’s Record Success Warns of a Dot-Com Bubble Burst. We’re Just Waiting for the Explosion.

The higher the mountain, the more treacherous the backside. Thus, investors should be wary of treating a cyclical peak like this one as a permanent plateau.

Michael Burry Says the Stock Market Has ‘Jumped the Shark.’ If He’s Right, This ETF Will Be Your Chum.

This inverse ETF lets you profit from a major decline in the S&P 500.

1 2 3 4 5

People

203,166 stories

Paul Tudor Jones

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

399,217 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play